Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6 (2003)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1038/sj.tpj.6500160
- Subjects: FARMACOLOGIA CLÍNICA; FARMACOLOGIA MÉDICA; FARMACODINÂMICA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 3, n. 2, p. 105-113, 2003
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DESAI, M. et al. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6. The Pharmacogenomics Journal, v. 3, n. 2, p. 105-113, 2003Tradução . . Acesso em: 29 set. 2023. -
APA
Desai, M., Tanus-Santos, J. E., Li, L., Gorski, J. C., Arefayene, M., Liu, Y., et al. (2003). Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6. The Pharmacogenomics Journal, 3( 2), 105-113. doi:10.1038/sj.tpj.6500160 -
NLM
Desai M, Tanus-Santos JE, Li L, Gorski JC, Arefayene M, Liu Y, Desta Z, Flockhart DA. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6. The Pharmacogenomics Journal. 2003 ; 3( 2): 105-113.[citado 2023 set. 29 ] -
Vancouver
Desai M, Tanus-Santos JE, Li L, Gorski JC, Arefayene M, Liu Y, Desta Z, Flockhart DA. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6. The Pharmacogenomics Journal. 2003 ; 3( 2): 105-113.[citado 2023 set. 29 ] - Atorvastatina reduz a hipertensão arterial pulmonar causada por embolia pulmonar aguda (EPA) em ratos
- Chronic antihypertensive effects of sodium nitrite in L-name-induced hypertension in rats
- eNos haplotype associated with hypertension in obese children and adolescents
- Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions
- Sodium nitrite does not inhibit circulating angiotensin converting enzyme activity
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism
- Matrix metalloproteinases as drug targets in preeclampsia
- Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension
- Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms
Informações sobre o DOI: 10.1038/sj.tpj.6500160 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
